Pradžia › Melanoma › Ilinoisas
Melanoma klinikiniai tyrimai Ilinoisas
22 tyrimai dėl Melanoma ieško dalyvių vietose Ilinoisas.
Miestai Ilinoisas
- Chicago15 tyrimai
- Evanston8 tyrimai
- Cicero7 tyrimai
- Aurora7 tyrimai
- Champaign6 tyrimai
- Peoria6 tyrimai
- Decatur5 tyrimai
- Bloomington5 tyrimai
- Danville5 tyrimai
- Naperville5 tyrimai
- Springfield5 tyrimai
- Waukegan5 tyrimai
- Charleston4 tyrimai
- North Peoria4 tyrimai
- Galesburg4 tyrimai
- Carbondale3 tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- ir dar 54
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- University of Illinois Cancer Center, Chicago
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06172478DESTINY-PANTUMOUR04
- Research Site, Decatur
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Rush-Copley Medical Center, Aurora
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- ir dar 38
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Hope and Healing Cancer Services, Hinsdale
- Advocate Lutheran General Hospital, Park Ridge
- Illinois CancerCare, Peoria
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06246916Pan-tumor MRD Study
- Cancer Care Specialists of Illinois (CCSI), O'Fallon
- Carle Health, Urbana
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Loyola Center for Health at Burr Ridge, Burr Ridge
- Northwestern University, Chicago
- Swedish Covenant Hospital, Chicago
- ir dar 8
Renkami dalyviai3 fazė
Amžius 75 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT07068074A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Saint Anthony's Health, Alton
- Rush - Copley Medical Center, Aurora
- Illinois CancerCare-Bloomington, Bloomington
- ir dar 33
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT04511013Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Northwestern University, Chicago
- Memorial Hospital East, Shiloh
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT05896839Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Lurie Children's Hospital-Chicago, Chicago
Renkami dalyviai1/2 fazė
12 Months – 30 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT04851119Project: Every Child for Younger Patients With Cancer
- Rush-Copley Medical Center, Aurora
- Lurie Children's Hospital-Chicago, Chicago
- Northwestern University, Chicago
- ir dar 16
Renkami dalyviaiStebimasis tyrimas
Iki 25 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT02402244A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Orchard Healthcare Research Inc, Skokie
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT06330064Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
- Northwestern University, Chicago
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-10 · NCT07556380A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Call for Information (Investigational Site 0024), Chicago
Renkami dalyviai1/2 fazė
6 Months – 17 Years · Visoms lytims · Atnaujinta 2026-07-06 · NCT02332668Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 19 iki 110 · Visoms lytims · Atnaujinta 2026-06-29 · NCT02012699ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Chicago Medical Center, Chicago
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-13 · NCT03686124A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- University of Chicago, Chicago
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-28 · NCT06413680A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Northwestern Memorial Hospital, Chicago
- University of Chicago Medical Center, Chicago
Renkami dalyviai2/3 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-04-02 · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- ir dar 45
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-17 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2025-10-28 · NCT03452774Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Advocate Illinois Masonic Medical Center, Chicago
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb
- Northwestern University, Evanston
- ir dar 4
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2024-11-27 · NCT03860883Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
- Loyola University Medical Center, Maywood
Renkami dalyviai1 fazė
Amžius nuo 18 iki 89 · Visoms lytims · Atnaujinta 2018-03-12 · NCT02870244Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.